Page last updated: 2024-11-05

2,4-thiazolidinedione and Diabetic Glomerulosclerosis

2,4-thiazolidinedione has been researched along with Diabetic Glomerulosclerosis in 4 studies

thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.

Research Excerpts

ExcerptRelevanceReference
"In patients with type 2 diabetes, early use of TZDs may be beneficial in both achieving glucose control and reducing the development or worsening of microalbuminuria or hypertension."2.42Hypertension and nephropathy. ( Bakris, GL, 2003)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banerji, MA1
Purkayastha, D1
Francis, BH1
Bakris, GL1
Ina, K1
Ohga, S1
Shikata, K1
Yozai, K1
Okada, S1
Ogawa, D1
Usui, H1
Wada, J1
Shikata, Y1
Makino, H1

Reviews

1 review available for 2,4-thiazolidinedione and Diabetic Glomerulosclerosis

ArticleYear
Hypertension and nephropathy.
    The American journal of medicine, 2003, Dec-08, Volume: 115 Suppl 8A

    Topics: Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Hypertension, Renovascula

2003

Other Studies

3 other studies available for 2,4-thiazolidinedione and Diabetic Glomerulosclerosis

ArticleYear
Safety and tolerability of vildagliptin vs. thiazolidinedione as add-on to metformin in type 2 diabetic patients with and without mild renal impairment: a retrospective analysis of the GALIANT study.
    Diabetes research and clinical practice, 2010, Volume: 90, Issue:2

    Topics: Adamantane; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidy

2010
How about the effect of thiazolidinediones in diabetic nephropathy?
    Medical science monitor : international medical journal of experimental and clinical research, 2004, Volume: 10, Issue:6

    Topics: Albumins; Animals; Diabetic Nephropathies; Humans; Kidney Diseases; Lipid Metabolism; Rats; Thiazoli

2004
Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.
    American journal of physiology. Renal physiology, 2007, Volume: 292, Issue:4

    Topics: Anilides; Animals; Anti-Inflammatory Agents; Cells, Cultured; Collagen Type IV; Diabetes Mellitus, E

2007